Release Notes – Caristix 3.2
October 22, 2014
Caristix release 3.2 is a broad release of additional features through the range of Caristix products from Workgroup through the individual HL7 modules, Cloak, Conformance,
Caristix release 3.2 is a broad release of additional features through the range of Caristix products from Workgroup through the individual HL7 modules, Cloak, Conformance,
Cost and technical barriers? As soon as you hear the word “interoperability” in healthcare, “cost” and “complexity” are right around the corner. If you’re a
Interface Conversion Projects: 10 or More Steps If you’ve ever worked on converting from a legacy interface engine to a new one, you know one
When you first start researching the interfacing capabilities of each engine vendor, you might be overwhelmed. If you’re in a startup, small company, or a
De-identification is a technique to mask or remove protected health information (PHI) from sensitive patient data. If you need to use production HL7 data, you’ll
It’s been 2 years this fall that we started publishing the HL7® Survival Guide chapter by chapter. It’s proven to be our most popular download
Requirements Thinking What are HL7 requirements? First, in the world of software engineering, requirements refer to documented needs that an application or system must perform.
Tip 25 in the Interoperability Tip Series This is our last tip in the Interoperability Tip Series. Read the entire series here. The fact is
Why consider reverse-engineering? Lack of accurate specs If you’ve worked on an interfacing team or for HIE, one of the issues you’ll hear about is
Tip 24 in the Interoperability Tip Series Read Part 1 here In our previous tip we asked: why document HL7 profiles and specs. In beginning
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.